Tag: IONKF

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) DTC Eligibility Promotes Convenience, Liquidity for Investors

West Coast cannabis holding company IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) announced in September that it has obtained eligibility from the Depository Trust Company (“DTC”) for its shares on the U.S. OTC Markets (http://cnw.fm/Hc2HJ). An article discussing the company reads, “The DTC uses an electronic method of clearing securities, which speeds up the receipt of stocks and cash, accelerates the settlement process for investors and reduces transactional costs. DTC eligibility enables the stock to be traded over a wider selection of brokerage firms, because DTC eligibility is required by many as a measure of compliance. . . . DTC eligibility enables IONIC Brands to begin trading shares on its domestic market, where brand recognition is high, CEO and Director John Gorst said in a news release. ‘The ability for investors to electronically transfer between brokerages in the U.S. is significantly more convenient and provides to existing investors the benefit from greater liquidity and execution speeds, while attracting new investors to gain access that may have been previously restricted from investing in IONIC Brands,’ Gorst concluded.”

To view the full article, visit http://cnw.fm/6I9Di

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused, cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – 3 Things That Could Characterize the Marijuana 2.0 Launch in Canada

October 17 marked the one-year commemoration of recreational marijuana legalization in Canada. After the legalization of marijuana in 2018, Canadian regulators were fast in developing regulations for marijuana leaf and oil products. However, it took them longer to establish rules for cannabis products such as edibles, cannabis-infused drinks, and concentrates used in vape pens. Implementation of the new regulations led to the opening of a new market, referred to as Cannabis 2.0. Below are the three things that could characterize the Cannabis 2.0 market on the day of their legalization.

  1. No New Product in the Market

Despite the hype surrounding the launch of the cannabis 2.0 market, the event will not be exciting as it was during the launch of the first marijuana market in Canada because no new cannabis derivative product will be introduced in the market.

Licensed marijuana producers are required by law to issue a 60-day notice to Health Canada before selling marijuana products even though the new regulations for cannabis derivatives are already in effect. The consumers will therefore not be able to get their hands on cannabis derivatives until mid-December.

Since the launch of the cannabis 2.0 market comes before the holiday, it will be a while before it can be determined how the market performs and how the holidays affected sales. Reports for the cannabis 2.0 sales for the first quarter of sales will come in February 2020.

  1. Uncertainty Surrounding Cannabis-Infused Beverages And Vaping Products

Analysts and investors will be anxiously waiting for the sales data from the first quarter, which will be more focused on the sale of cannabis-infused beverages and vaping products.

There is much uncertainty surrounding cannabis-infused beverages, and this has forced some companies such as Aurora Cannabis to opt-out of developing cannabis-infused drinks due to the expected low market share of the products, said Cam Battley, the CEO of Aurora Cannabis in the company’s fiscal 2019 Q3 conference in May.

Canopy Growth, in collaboration with Constellation Brands, has developed several types of beverages meant to go up on the shelves later in the year.

Both Aurora and Canopy plan on launching vaping products in the markets, but with the recent scare of vaping-related illness, they are uncertain of how the product will perform and if it will be banned.

  1. Cannabis Edibles Will Attract Huge Sales

Due to the skepticism surrounding vaping products and cannabis-infused beverages, cannabis edibles seem like the safest option to introduce during the launch of cannabis 2.0. Thus, most cannabis producers are planning on producing a variety of cannabis edibles.

For example, Aurora Cannabis plans on producing cannabis chocolate, gummies, and mints. According to Bruce Linton, Canopy Growth plans on creating every type of cannabis edible you can come up with. However, when the former CEO of Canopy, Bruce Linton, made these remarks, the new cannabis regulation had not been finalized by Health Canada.

It is thought that marijuana industry players like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and IONIC Brands Inc. (CSE: IONC) (OTC: IONKF) would wish to for large market like the U.S. to have a uniform law regulating cannabis in all its forms as is the case in Canada, but that still seems to be far off.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Capitalizing on Adult-Use Cannabis Industry by Anticipating Market Movement

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a West Coast cannabis holding company, is focused on exploiting the adult-use cannabis industry by finding where the market is and anticipating where it’s going, especially in regards to technology. An article discussing the company reads, “IONIC Brands is developing a premium and luxury consumer portfolio led by a multistate, consumer-focused cannabis concentrate brand. Its base is on the West Coast, where the adult-recreational-use market for cannabis is booming with the largest volume of business in the world. . . . The company’s product line includes six cannabis formulations presented in three distinctive mood offerings designed to appeal to recreational users according to the consumers’ preferences for rich sociability, serene relaxation or enlightened creativity (http://cnw.fm/z06Vz).”

To view the full article, visit http://cnw.fm/2waFK

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused, cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Reports Milestone Q2 Revenues, Completes Transformational Acquisitions

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a West Coast cannabis holding company specializing in the recreational adult-product market, recently reported second-quarter 2019 financial results, including a revenue milestone of $5.9 million (http://cnw.fm/8Ueu8). An article discussing the company reads, “‘We are very pleased with our second quarter financial results, achieving our focus of increasing sales growth while closing a successful financing for various strategic business acquisitions all in a span of three months,’ John Gorst, chairman and CEO of IONIC Brands, stated in a news release. . . . Several transformational acquisitions were recently completed, adding to IONIC’s multistate portfolio of award-winning cannabis brands, Gorst added. The purchase of Vegas Valley Growers North (‘VVG’), a Las Vegas-based, state-licensed cultivation and manufacturing firm for medical and recreational cannabis, brings to IONIC a vertically integrated, cash-flow positive opportunity for additional projected 2019 revenue of $6.6 million, as well as expected gross profits of $3.1 million and EBITDA of $2 million, the company stated in a news release (http://cnw.fm/sU4K7).”

To view the full article, visit http://cnw.fm/e2OwQ

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused, cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Federally Funded Study Disproves Marijuana Legalization Myths

A new study on the impacts of marijuana, which was funded by the U.S. Department of Justice, showed that marijuana programs do not affect neighboring or non-legal states negatively.

The new study authors, while conducting their state-level analysis, were looking to answer three questions; first, the impact of legalization on law enforcement resources in legal states. Secondly, how those resources in bordering and non-legal states are affected, and lastly, what it means for drug trafficking after marijuana is legalized.

The researchers used past statistics on drug possession and distribution in the legalized states as well as the neighboring non-legal states to assess the impact of marijuana legalization. The analyzed data showed that legalization did not have any noticeable increase in the number of arrests related to possession or trafficking offenses in legalized or non-legalized states.

Although the Department of Justice funded the study, they do not want the public thinking that they are endorsing the findings because, on every page of the report, there is disclaimer which stresses that the authors’ opinion does not reflect the standpoint or policies of the Department of Justice in the U.S.

The study found that in Washington, there was a decline in the number of possession arrests after cannabis was legalized in 2012, followed by a decrease in distribution arrests after retail sales were introduced.

Marijuana was legalized in 2014 in Oregon, and since the study was carried out in 2015, there was not enough data. However, the little data that was available showed that possession arrests post-legalization dropped close to zero, followed by distribution arrests.

In Oklahoma, which is a non-legal state bordering Colorado, the majority of drug arrests consisted of marijuana possession. However, the number of arrests for marijuana possession declined after marijuana was legalized in Colorado. The number of distribution arrests also decreased, with a small increase in 2013.

There were also noticeable changes in Kansas after marijuana was legalized in the neighboring state of Colorado

The report was supplemented with interviews from law enforcement officials who expressed their concern saying that they have more work due to the perceived increase in young adult usage, THC potency of marijuana, driving under the influence, and an influx of marijuana consumers from non-legal to legal states.

The findings from the Colorado interviews showed that due to the high potency of the THC products, the influence of the drug cartels in the markets has been thwarted. However, in Oregon, there is a spike in drug trafficking by the Afghan and Russian groups stealing marijuana crops and cash from farmers.

The team concluded that, indeed, recreational marijuana legalization results in a dip in possession and trafficking arrests in legalized and non-legal bordering states and that other drugs such as heroin and methamphetamine were the ones having the most impact.

It is believed that marijuana industry players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) aren’t surprised by these research findings, and they are glad that the federal government funded the study which debunks the myths regarding marijuana legalization.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – A New Study Aims to Find if Marijuana Can be Used to Treat Symptoms of Autism

Montefiore Medical Center in New York is conducting a clinical trial which will examine the effects of cannabidivarin (CBDV) on the level of irritation and repetitive behaviors in autistic children. Cannabidivarin is a compound of marijuana that is nonpsychoactive and does not induce highness upon consumption.

GW Pharmaceuticals grows the cannabis to be used during the research. The company occupies 47-plus acres in the English countryside and is the first drug company to develop cannabis-related medicine which was approved by the U.S. Food and Drug Administration. Two rare types of epilepsy are treated using the drug.

Dr Sanjay Gupta, who is a CNN Chief Medical Correspondent, got exclusive access to the clinical trials In Montefiore Medical Center and GW Pharmaceuticals company.

While reporting for Weed 5 on the cannabinoid craze, Gupta had an exclusive look at GW  cannabis greenhouses. The greenhouses occupy the 47 acres allowing for consistent breeding of different strains of the marijuana crop for medicine. According to David Cooper, head of manufacturing in the company, the process of developing and mastering different strains of the cannabis plant is challenging. During the tour, David showed Gupta the process of turning different strains of the plant into medicine for the large pool of patients.

Gupta also found that GW Pharmaceuticals has been in operation for the last 20 years. Moreover, towards the end of 2018, the company launched Epidiolex.

Epidiolex is the first cannabis-related oral medication to be approved by the FDA. It is used for treating two rare epilepsy disorders. During the clinical trials, Epidiolex reduced the severity of seizure in patients with Dravet Syndrome by an average of 45%-50%. Epidiolex is made of cannadidiol, which is an extracted compound of the cannabis plant.

Epidiolex’s success in treating epilepsy motivated GW Pharmaceutical to manufacture another cannabis-based drug for treating people with a neurological disorder known as autism. Epilepsy and autism have similar symptoms such as loss of cognitive function, poor language skills, and poor socialization skills.

The Director of the AOCD (Autism and Obsessive Compulsive Spectrum, Anxiety and Depression) Program at Montefiore Hospital, Dr Eric Hollander, gets CBDV (cannabidivarin) from GW Pharmaceuticals in UK for the clinical trials. Based on the success of CBDV to reduce seizures, he believes that the hope for treating autism symptoms is in the extract.

Hollander further says that CBDV could help in reducing aggression, self-injury or temper tantrums in autist patients. The clinical trials are headed by Hollander who has 30 years’ experience researching autism. According to Hollander, autism and epilepsy have simiar symptoms.

Autism has no cure. Therefore, Hollander’s focus is on treating the underlying causes of autism, and use of CBDV could help remedy the symptoms.

When CBDV was administered in animals having similar symptoms to autism, the researchers saw that it had significant effect on social functioning, increased cognitive function, less seizures and a reduction in compulsive and repetitive behaviors, thus their application of CBDV on autistic patients.

The clinica trials involve 100 participtants, who are aged between 5-18 years. The treatment takes 12 weeks and will be finalized in September 2021.

It is widely expected that marijuana industry players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) will be eager to learn the outcomes of this autism research.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Reports Q2 Revenues Up 377%

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a West Coast cannabis holding company specializing in the recreational adult-product market, recently announced impressive second-quarter financial results. An article discussing the company reads, “IONIC saw a year-over-year increase of 377% in sales for the period ended June 30, leaving the company $3.86 million better than the prior year. The sales increase was largely due to an increase in services, packaging and ancillary products to its customers and their downstream sales, as well as an increase in licensing and equipment rental revenue to those customers. Two acquisitions also played into the revenue picture. . . . ‘We are very pleased with our second-quarter financial results, achieving our focus of increasing sales growth while closing a successful financing for various strategic business acquisitions all in a span of three months,’ chairman and CEO John Gorst stated in an August 29 news release announcing the results (http://cnw.fm/UK5fN).”

To view the full article, visit http://cnw.fm/P9pkc

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused, cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Temporarily Suspends Production in California Amid Vape Product Safety Concerns

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) this morning provided an update addressing the recent vaporizer product safety concerns. In the release, IONKF reiterated its concentration on safety and its commitment to self-regulating above and beyond required regulations and quality measures. In light of the recent vaping events, and in response to the company’s concern with illegal and unregulated black-market products in California, IONKF has temporarily suspended production in California until regulators can address the issue. “This is a situation that we take seriously and are monitoring closely,” IONIC Brands CEO and chairman John Gorst stated in the news release.

To view the full press release, visit http://cnw.fm/R4ntV

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Medical Marijuana Legalization Bill Introduced in Wisconsin

Three legislators in Wisconsin have united to introduce a bill legalizing the use of marijuana for medicinal purposes. The legislators include two Democrats, Erpenbach and Taylor, and Testin who is a Republican.

Sen. Jon Erpenbach, Taylor and Testin in a joint statement on Friday announced that the time has come for the state of Wisconsin to lift the restrictions and legalize the use of marijuana. The bill would create a system that allows patients to be entered into a list through registration and the growers to be issued with a license permitting them to grow cannabis for medical purposes.

In the United States, there are 33 states legally using marijuana either for medical or recreational purposes. Among these are, Michigan and Minnesota. In Colorado and nearly a dozen other states, residents can use marijuana for medical and recreational purposes.

In the statement, Testin said that the government should not decide if marijuana is right for inducing treatment; doctors and patients should be given that mandate to determine if cannabis is right for treating a particular condition.

For the past decade, the Democrats have been trying to pass marijuana legalization bills with no success. However, it is still uncertain whether with the Republican support exemplified by Testin, the bill will be passed into law. Speaker of the Assembly, Robin Vos is open to passing the bill but the Senate Majority Leader, Scott Fitzgerald has openly voiced his opposition.

Tony Evers, the Democratic governor, had proposed legalization of medical marijuana, in the Winsconsin budget, but the provisions were not included in the final budget plan.

Through his spokesman, the governor did not comment on the bill. Moreover, since he is running for Congress in the year 2020 in a Wisconsin district that is traditionally conservative, his stand on the bill is unlikely to change. Supporting the bill would pose a threat for him as it would be a motivating factor for his primary challengers.

The proposed marijuana legalisation bill has the following terms that have to be met by the doctors, patients and the cannabis growers.

Persons qualifying to receive medical marijuana have to be suffering from one of the following ailments; AIDS, cancer, Alzheimer’s, PTSD (post-traumatic stress disorder), traumatic brain injury (TBI), and severe and chronic pain.

Before being registered and joining the list of people to receive medical marijuana treatment, a doctor should diagnose the patient, explain the risk factors as well as the benefits of using medical marijuana.

Patients applying to receive medical marijuana are supposed to pay $250 for registration and $250 in annual fees.

The marijuana registry is not visible to the public and people who are or have been convicted of a drug-related crime are not allowed to join the list.

The Department of Agriculture, Trade and Consumer Protection would set up a licensing system for the growers, if the bill remains as it is. The licensed growers would include persons growing a dozen-plus marijuana plants. Grower would have to pay an initial fee of $250 and an annual fee of $5000. The licensed growers would also be prohibited from growing cannabis for family or personal consumption.

On Friday, Evers tweeted his supports for the bill while pointing to a recent poll by the Marquette University Law School which showed that 83 percent supported the legalization of medical marijuana. In the tweet he wrote that now was the time for physicians to be allowe to prescribe the medication that they felt was best placed to treat their patients.

Analysts believe that the chances of this bill sailing through are too close to call, and they also believe that industry players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) would wish that patients have the option of using medical marijuana sooner rather than later.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Secures DTC Eligibility for U.S. Markets

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) on Wednesday announced that it has achieved eligibility by The Depository Trust Company (“DTC”) for its shares on the OTC Market in the United States. DTC, a subsidiary of the Depository Trust & Clearing Corporation (“DTCC”), manages the electronic clearing and settlement of publicly traded companies. This method accelerates the receipt of stock and cash, fast-tracks the settlement process for investors and brokers and cuts transactional costs for participating brokerage firms. DTC eligibility enables stock to be traded over a significantly broader selection of brokerage firms, as several firms require DTC eligibility as a compliance measure. “We are pleased to have secured DTC eligibility that allows trading of our shares in our home market, where IONIC BRANDS recognition is strong and most of our earliest investors reside. The ability for investors to electronically transfer between brokerages in the U.S. is significantly more convenient and provides to existing investors the benefit from greater liquidity and execution speeds, while attracting new investors to gain access that may have been previously restricted from investing in IONIC BRANDS,” IONIC Brands CEO & director John Gorst stated in the news release.

To view the full press release, visit http://cnw.fm/2nJMv

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is one of the top vaporizer brands in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com